Posted on 11/08/2010 in Medical Company Financials Smith and Nephew has highlighted its business growth during the second quarter of 2010 in its newly-published financial report.
The medical device manufacturer has reported quarterly revenues of $959 million (611.4 million pounds) for the three months ending July 3rd 2010, which represents an underlying growth of four per cent.
Among the business divisions to benefit from this growth were its European orthopaedics and endoscopy units, while advanced wound management sales outperformed the wider market.
David Illingworth, chief executive of Smith and Nephew, expressed confidence in the firm's continued growth, despite the financial pressures faced by many of its clients.
He said: "The long-term industry growth drivers - including demographics, emerging markets and patients' desire to return to an active life - remain intact."
Last month, Smith and Nephew published a report highlighting its success in sustainability and corporate responsibility initiatives over the last year, having recently been included on the Dow Jones Sustainability Index. Other news stories from 11/08/2010
Read more in the Zenopa News Archive
How this news is generated
|
